

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63863668 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.63863668 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28977786 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.28977786 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.90094751 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.25940628 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.24298527 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.24298527 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.24298527 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.10131881 |
| 11 | bile acid biosynthetic process (GO:0006699) | 6.01128369 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.87243507 |
| 13 | urea metabolic process (GO:0019627) | 5.75965508 |
| 14 | urea cycle (GO:0000050) | 5.75965508 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.75360307 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65261111 |
| 17 | positive regulation of catecholamine secretion (GO:0033605) | 5.64054143 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.59041627 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.51469351 |
| 20 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 5.50097105 |
| 21 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 5.50097105 |
| 22 | regulation of plasminogen activation (GO:0010755) | 5.43163711 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.42417150 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.39836680 |
| 25 | protein carboxylation (GO:0018214) | 5.38609715 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38609715 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.38077154 |
| 28 | cysteine metabolic process (GO:0006534) | 5.35433205 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.33824948 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.29383252 |
| 31 | regulation of oxidative phosphorylation (GO:0002082) | 5.16432262 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.13610465 |
| 33 | bile acid metabolic process (GO:0008206) | 5.13424107 |
| 34 | regulation of autophagic vacuole assembly (GO:2000785) | 5.07350049 |
| 35 | regulation of complement activation (GO:0030449) | 5.03539930 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 5.00907119 |
| 37 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.99501581 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87651818 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.86904983 |
| 40 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.86509593 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.84811653 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.82697164 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.81563973 |
| 44 | microtubule nucleation (GO:0007020) | 4.79693624 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.78906498 |
| 46 | cellular response to zinc ion (GO:0071294) | 4.77262395 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.73119437 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.73119437 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.73119437 |
| 50 | pteridine-containing compound biosynthetic process (GO:0042559) | 4.72651314 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.68457415 |
| 52 | organic cation transport (GO:0015695) | 4.67047292 |
| 53 | desmosome organization (GO:0002934) | 4.64204710 |
| 54 | lysine catabolic process (GO:0006554) | 4.62166327 |
| 55 | lysine metabolic process (GO:0006553) | 4.62166327 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.61818969 |
| 57 | retinal cone cell development (GO:0046549) | 4.60225916 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.59623087 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.59623087 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.56690855 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.56690855 |
| 62 | phospholipid efflux (GO:0033700) | 4.52341955 |
| 63 | SMAD protein complex assembly (GO:0007183) | 4.51486542 |
| 64 | galactose catabolic process (GO:0019388) | 4.50068039 |
| 65 | regulation of oxidative stress-induced neuron death (GO:1903203) | 4.45849582 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.45570303 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.43638348 |
| 68 | glycine metabolic process (GO:0006544) | 4.42990864 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 4.42172775 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 4.40674613 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 4.39571038 |
| 72 | cell migration involved in heart development (GO:0060973) | 4.38318346 |
| 73 | kidney morphogenesis (GO:0060993) | 4.36466718 |
| 74 | amine catabolic process (GO:0009310) | 4.33679975 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.33679975 |
| 76 | cellular glucuronidation (GO:0052695) | 4.33526171 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 4.33372696 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 4.30013793 |
| 79 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 4.27130454 |
| 80 | glutamate metabolic process (GO:0006536) | 4.25888332 |
| 81 | zinc ion transmembrane transport (GO:0071577) | 4.25496366 |
| 82 | cholesterol efflux (GO:0033344) | 4.20363662 |
| 83 | mRNA cleavage (GO:0006379) | 4.19332762 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 4.19205507 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 4.14062827 |
| 86 | regulation of vacuole organization (GO:0044088) | 4.13945074 |
| 87 | ethanol oxidation (GO:0006069) | 4.12491201 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 4.06489054 |
| 89 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06318836 |
| 90 | peptidyl-histidine modification (GO:0018202) | 4.05257687 |
| 91 | arginine metabolic process (GO:0006525) | 4.04846928 |
| 92 | phosphate ion transport (GO:0006817) | 4.02216973 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 4.00613728 |
| 94 | fibrinolysis (GO:0042730) | 4.00606580 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00381060 |
| 96 | aldehyde catabolic process (GO:0046185) | 3.99192413 |
| 97 | galactose metabolic process (GO:0006012) | 3.96345430 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 3.96278402 |
| 99 | inner ear receptor cell development (GO:0060119) | 3.94929674 |
| 100 | drug catabolic process (GO:0042737) | 3.92418401 |
| 101 | protein hydroxylation (GO:0018126) | 3.88028135 |
| 102 | pancreas development (GO:0031016) | 3.86549096 |
| 103 | insulin secretion (GO:0030073) | 3.86354445 |
| 104 | negative regulation of meiotic cell cycle (GO:0051447) | 3.85165107 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.84854170 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.84728364 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.84728364 |
| 108 | phosphate ion transmembrane transport (GO:0035435) | 3.84523563 |
| 109 | cofactor catabolic process (GO:0051187) | 3.82378343 |
| 110 | ketone body metabolic process (GO:1902224) | 3.81456581 |
| 111 | complement activation, classical pathway (GO:0006958) | 3.80837563 |
| 112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80058902 |
| 113 | complement activation (GO:0006956) | 3.77440077 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76565854 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 3.75702865 |
| 116 | phospholipid homeostasis (GO:0055091) | 3.75314651 |
| 117 | organic acid catabolic process (GO:0016054) | 3.75136840 |
| 118 | carboxylic acid catabolic process (GO:0046395) | 3.75136840 |
| 119 | negative regulation of lipase activity (GO:0060192) | 3.74581268 |
| 120 | protein activation cascade (GO:0072376) | 3.74190096 |
| 121 | cytolysis (GO:0019835) | 3.74003234 |
| 122 | cholesterol homeostasis (GO:0042632) | 3.72937559 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 3.72421590 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71875630 |
| 125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71875630 |
| 126 | cellular response to cadmium ion (GO:0071276) | 3.68322182 |
| 127 | sterol homeostasis (GO:0055092) | 3.66687785 |
| 128 | short-chain fatty acid metabolic process (GO:0046459) | 3.65217163 |
| 129 | regulation of cholesterol homeostasis (GO:2000188) | 3.63800469 |
| 130 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.59325899 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 3.58825625 |
| 132 | NAD biosynthetic process (GO:0009435) | 3.57583524 |
| 133 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.56859624 |
| 134 | multicellular organism reproduction (GO:0032504) | 3.56620475 |
| 135 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.56160935 |
| 136 | protein-lipid complex assembly (GO:0065005) | 3.54975769 |
| 137 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.54655266 |
| 138 | positive regulation of actin filament depolymerization (GO:0030836) | 3.51859887 |
| 139 | male meiosis (GO:0007140) | 3.49061546 |
| 140 | activation of protein kinase A activity (GO:0034199) | 3.42544883 |
| 141 | cardiac muscle cell proliferation (GO:0060038) | 3.42485265 |
| 142 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.40012547 |
| 143 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.35534721 |
| 144 | primary amino compound metabolic process (GO:1901160) | 3.35066889 |
| 145 | polyamine biosynthetic process (GO:0006596) | 3.34646377 |
| 146 | adenosine metabolic process (GO:0046085) | 3.33811521 |
| 147 | positive regulation of TOR signaling (GO:0032008) | 3.19266496 |
| 148 | white fat cell differentiation (GO:0050872) | 3.18720657 |
| 149 | acrosome reaction (GO:0007340) | 3.15887484 |
| 150 | negative regulation of response to extracellular stimulus (GO:0032105) | 3.15417851 |
| 151 | negative regulation of response to nutrient levels (GO:0032108) | 3.15417851 |
| 152 | response to lead ion (GO:0010288) | 3.14667488 |
| 153 | regulation of gonadotropin secretion (GO:0032276) | 3.12664280 |
| 154 | regulation of cellular respiration (GO:0043457) | 3.12442865 |
| 155 | positive regulation of myoblast differentiation (GO:0045663) | 3.11849412 |
| 156 | regulation of response to food (GO:0032095) | 3.10512335 |
| 157 | potassium ion export (GO:0071435) | 3.08926863 |
| 158 | response to BMP (GO:0071772) | 3.08817135 |
| 159 | cellular response to BMP stimulus (GO:0071773) | 3.08817135 |
| 160 | fatty acid beta-oxidation (GO:0006635) | 3.07409402 |
| 161 | sperm motility (GO:0030317) | 3.06647023 |
| 162 | potassium ion import (GO:0010107) | 3.05669764 |
| 163 | homeostasis of number of cells within a tissue (GO:0048873) | 3.04224658 |
| 164 | 4-hydroxyproline metabolic process (GO:0019471) | 3.03479261 |
| 165 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.01202574 |
| 166 | rRNA methylation (GO:0031167) | 3.00569303 |
| 167 | innervation (GO:0060384) | 2.99137380 |
| 168 | energy homeostasis (GO:0097009) | 2.97139354 |
| 169 | purine nucleotide salvage (GO:0032261) | 2.96821222 |
| 170 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.96490544 |
| 171 | indole-containing compound metabolic process (GO:0042430) | 2.96079423 |
| 172 | cartilage morphogenesis (GO:0060536) | 2.95364063 |
| 173 | negative regulation of macrophage differentiation (GO:0045650) | 2.93420855 |
| 174 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.92699439 |
| 175 | cGMP-mediated signaling (GO:0019934) | 2.90893127 |
| 176 | androgen biosynthetic process (GO:0006702) | 2.90411784 |
| 177 | gluconeogenesis (GO:0006094) | 2.82959870 |
| 178 | peptide hormone secretion (GO:0030072) | 2.82174449 |
| 179 | spermatid development (GO:0007286) | 2.79054970 |
| 180 | hexose biosynthetic process (GO:0019319) | 2.77132932 |
| 181 | retinol metabolic process (GO:0042572) | 2.76786050 |
| 182 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.76504085 |
| 183 | striated muscle cell proliferation (GO:0014855) | 2.75400580 |
| 184 | maintenance of protein location in nucleus (GO:0051457) | 2.73688572 |
| 185 | TOR signaling (GO:0031929) | 2.73624579 |
| 186 | single fertilization (GO:0007338) | 2.72390565 |
| 187 | nucleoside transport (GO:0015858) | 2.72309486 |
| 188 | peptide secretion (GO:0002790) | 2.71920285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42041785 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20032128 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10040631 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53399797 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24374093 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12640742 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.79681991 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.07870410 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.91519226 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.69208755 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.47971117 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.41304867 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.39109982 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10689975 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.09441598 |
| 16 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9370944 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96204947 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95955289 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.90849236 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.87865685 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85715910 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75318252 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74600362 |
| 24 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.64707145 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62172433 |
| 26 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61066043 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59473701 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55653590 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.50121033 |
| 30 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.48357662 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46356373 |
| 32 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.44470216 |
| 33 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.43408789 |
| 34 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41207952 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.35675802 |
| 36 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34358906 |
| 37 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31969587 |
| 38 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31077938 |
| 39 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26942759 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26470651 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25520221 |
| 42 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24956515 |
| 43 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.23020767 |
| 44 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22901378 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22901378 |
| 46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21776795 |
| 47 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21367623 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20264031 |
| 49 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19551308 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18844211 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17803648 |
| 52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17780364 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17275499 |
| 54 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17189304 |
| 55 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.15706100 |
| 56 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.13767620 |
| 57 | * NFYB_21822215_ChIP-Seq_K562_Human | 1.13341234 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13087151 |
| 59 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.09743443 |
| 60 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.09065629 |
| 61 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08549292 |
| 62 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.07389236 |
| 63 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.06168496 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05993890 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.04679380 |
| 66 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04312680 |
| 67 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.04253103 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03499163 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03199700 |
| 70 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.02732703 |
| 71 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.02659890 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01731167 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00769068 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00459505 |
| 75 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.99814714 |
| 76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99113639 |
| 77 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97737247 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97478013 |
| 79 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97284107 |
| 80 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97199265 |
| 81 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97199265 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96331801 |
| 83 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95234351 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94293198 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.94201175 |
| 86 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93165539 |
| 87 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.92625322 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92371586 |
| 89 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.92287338 |
| 90 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91705173 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.91637315 |
| 92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91551240 |
| 93 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.91404751 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91275827 |
| 95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.90575100 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90534870 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90534870 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.89683752 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88262186 |
| 100 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88037756 |
| 101 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.87976697 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86757925 |
| 103 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86427934 |
| 104 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.86426405 |
| 105 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86199275 |
| 106 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85189217 |
| 107 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.84846282 |
| 108 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.84334007 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84308796 |
| 110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83779226 |
| 111 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83187161 |
| 112 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82614041 |
| 113 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82198298 |
| 114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81998626 |
| 115 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81958229 |
| 116 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81732412 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80609199 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80063377 |
| 119 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.79710505 |
| 120 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.79525542 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78185729 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77626709 |
| 123 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77240102 |
| 124 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77169455 |
| 125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74898356 |
| 126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73373962 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72888731 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71467525 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70953477 |
| 130 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69441731 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67045862 |
| 132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67045862 |
| 133 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64010328 |
| 134 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63778506 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63511090 |
| 136 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62902193 |
| 137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60400804 |
| 138 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59208917 |
| 139 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58985990 |
| 140 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58105835 |
| 141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57601117 |
| 142 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56711703 |
| 143 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54129728 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53791959 |
| 145 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.53206061 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52809454 |
| 147 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52766151 |
| 148 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51686600 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51644907 |
| 150 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49843150 |
| 151 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49655759 |
| 152 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49481602 |
| 153 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48924486 |
| 154 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48841354 |
| 155 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48794114 |
| 156 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.48699198 |
| 157 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46338739 |
| 158 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.45750006 |
| 159 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44450114 |
| 160 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43916524 |
| 161 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43177141 |
| 162 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43136906 |
| 163 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43017161 |
| 164 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42228866 |
| 165 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41896034 |
| 166 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41252801 |
| 167 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41188007 |
| 168 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40592001 |
| 169 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39981014 |
| 170 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39733670 |
| 171 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39596738 |
| 172 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39539122 |
| 173 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39234850 |
| 174 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.39195904 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38850318 |
| 176 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38489592 |
| 177 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37829415 |
| 178 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37657007 |
| 179 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37456302 |
| 180 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37003866 |
| 181 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36038713 |
| 182 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34764617 |
| 183 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34502638 |
| 184 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34496878 |
| 185 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.34350361 |
| 186 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34340499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.46519033 |
| 2 | * MP0005360_urolithiasis | 6.80838265 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.62700824 |
| 4 | MP0005365_abnormal_bile_salt | 6.29183123 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.25648953 |
| 6 | MP0004043_abnormal_pH_regulation | 5.23074723 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.29438385 |
| 8 | MP0003252_abnormal_bile_duct | 4.01433597 |
| 9 | MP0000013_abnormal_adipose_tissue | 4.00697531 |
| 10 | MP0005646_abnormal_pituitary_gland | 3.80492909 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.63322763 |
| 12 | MP0005410_abnormal_fertilization | 3.39089016 |
| 13 | MP0009840_abnormal_foam_cell | 3.28370791 |
| 14 | MP0005083_abnormal_biliary_tract | 3.12790028 |
| 15 | MP0001984_abnormal_olfaction | 3.03355081 |
| 16 | MP0004885_abnormal_endolymph | 2.94247443 |
| 17 | MP0003195_calcinosis | 2.87865763 |
| 18 | MP0003315_abnormal_perineum_morphology | 2.73884391 |
| 19 | * MP0005332_abnormal_amino_acid | 2.70344991 |
| 20 | MP0003136_yellow_coat_color | 2.64375911 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.63003688 |
| 22 | MP0002132_abnormal_respiratory_system | 2.50659176 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.48955027 |
| 24 | MP0001664_abnormal_digestion | 2.31029161 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.27234815 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 2.23218180 |
| 27 | MP0000609_abnormal_liver_physiology | 2.20003632 |
| 28 | MP0008004_abnormal_stomach_pH | 2.16973017 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 2.16036962 |
| 30 | MP0000749_muscle_degeneration | 2.13598696 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 2.13553879 |
| 32 | MP0001944_abnormal_pancreas_morphology | 2.07141039 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 2.00242361 |
| 34 | MP0003868_abnormal_feces_composition | 1.99183865 |
| 35 | MP0002736_abnormal_nociception_after | 1.92852129 |
| 36 | MP0008995_early_reproductive_senescence | 1.89788539 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.85990942 |
| 38 | MP0001905_abnormal_dopamine_level | 1.81377781 |
| 39 | MP0001270_distended_abdomen | 1.79168268 |
| 40 | MP0002160_abnormal_reproductive_system | 1.75690418 |
| 41 | MP0003045_fibrosis | 1.72865607 |
| 42 | MP0008961_abnormal_basal_metabolism | 1.72084560 |
| 43 | MP0001764_abnormal_homeostasis | 1.70358939 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.68104754 |
| 45 | MP0009697_abnormal_copulation | 1.64067941 |
| 46 | MP0002938_white_spotting | 1.63709574 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58894639 |
| 48 | MP0002234_abnormal_pharynx_morphology | 1.54444701 |
| 49 | MP0005394_taste/olfaction_phenotype | 1.45297034 |
| 50 | MP0005499_abnormal_olfactory_system | 1.45297034 |
| 51 | MP0005451_abnormal_body_composition | 1.43269589 |
| 52 | MP0003011_delayed_dark_adaptation | 1.41154644 |
| 53 | MP0003633_abnormal_nervous_system | 1.34146682 |
| 54 | MP0003186_abnormal_redox_activity | 1.28249902 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.27323126 |
| 56 | MP0001929_abnormal_gametogenesis | 1.27023465 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.26008255 |
| 58 | MP0003698_abnormal_male_reproductive | 1.24015803 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.23388439 |
| 60 | MP0004147_increased_porphyrin_level | 1.20550263 |
| 61 | MP0000598_abnormal_liver_morphology | 1.19928644 |
| 62 | * MP0009643_abnormal_urine_homeostasis | 1.18175215 |
| 63 | MP0005647_abnormal_sex_gland | 1.16102576 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.15293978 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.13973640 |
| 66 | MP0005171_absent_coat_pigmentation | 1.12324350 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.11889550 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.11646902 |
| 69 | MP0005253_abnormal_eye_physiology | 1.11135753 |
| 70 | MP0009764_decreased_sensitivity_to | 1.07372914 |
| 71 | MP0000604_amyloidosis | 1.06971099 |
| 72 | MP0004085_abnormal_heartbeat | 1.06138964 |
| 73 | MP0002254_reproductive_system_inflammat | 1.04698737 |
| 74 | MP0004233_abnormal_muscle_weight | 1.04598687 |
| 75 | MP0004510_myositis | 1.03842702 |
| 76 | MP0009763_increased_sensitivity_to | 1.03752944 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 1.01762502 |
| 78 | MP0001765_abnormal_ion_homeostasis | 1.00715269 |
| 79 | MP0000470_abnormal_stomach_morphology | 0.98087049 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 0.98015135 |
| 81 | MP0003878_abnormal_ear_physiology | 0.97597010 |
| 82 | MP0005377_hearing/vestibular/ear_phenot | 0.97597010 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 0.95340056 |
| 84 | MP0010368_abnormal_lymphatic_system | 0.95215299 |
| 85 | MP0001145_abnormal_male_reproductive | 0.95172257 |
| 86 | MP0000653_abnormal_sex_gland | 0.92182314 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.91985456 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.91796824 |
| 89 | MP0003631_nervous_system_phenotype | 0.91704202 |
| 90 | MP0002210_abnormal_sex_determination | 0.90620124 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.90400861 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.90284405 |
| 93 | MP0004134_abnormal_chest_morphology | 0.90121528 |
| 94 | MP0002269_muscular_atrophy | 0.90010940 |
| 95 | MP0008469_abnormal_protein_level | 0.89789450 |
| 96 | MP0005670_abnormal_white_adipose | 0.87761272 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.87176031 |
| 98 | * MP0009642_abnormal_blood_homeostasis | 0.86919058 |
| 99 | MP0002233_abnormal_nose_morphology | 0.86751018 |
| 100 | MP0009250_abnormal_appendicular_skeleto | 0.86750677 |
| 101 | MP0005408_hypopigmentation | 0.86640170 |
| 102 | MP0005367_renal/urinary_system_phenotyp | 0.86006665 |
| 103 | MP0000516_abnormal_urinary_system | 0.86006665 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.85923072 |
| 105 | MP0001970_abnormal_pain_threshold | 0.85728840 |
| 106 | MP0002184_abnormal_innervation | 0.84014964 |
| 107 | MP0005389_reproductive_system_phenotype | 0.83816982 |
| 108 | MP0003936_abnormal_reproductive_system | 0.83254514 |
| 109 | MP0004036_abnormal_muscle_relaxation | 0.83168640 |
| 110 | MP0003937_abnormal_limbs/digits/tail_de | 0.83121459 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.82469751 |
| 112 | MP0005330_cardiomyopathy | 0.82022506 |
| 113 | MP0000026_abnormal_inner_ear | 0.81740069 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.80879663 |
| 115 | MP0002272_abnormal_nervous_system | 0.80818604 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.80744526 |
| 117 | MP0005174_abnormal_tail_pigmentation | 0.80093977 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.79932380 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.79880038 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.79024912 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 0.78968020 |
| 122 | MP0004215_abnormal_myocardial_fiber | 0.78917060 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.78655163 |
| 124 | MP0002876_abnormal_thyroid_physiology | 0.78297615 |
| 125 | MP0001486_abnormal_startle_reflex | 0.77946771 |
| 126 | MP0002102_abnormal_ear_morphology | 0.76603081 |
| 127 | MP0003935_abnormal_craniofacial_develop | 0.75719619 |
| 128 | MP0005220_abnormal_exocrine_pancreas | 0.75012594 |
| 129 | MP0004130_abnormal_muscle_cell | 0.73270086 |
| 130 | MP0002971_abnormal_brown_adipose | 0.72997282 |
| 131 | MP0005334_abnormal_fat_pad | 0.70793270 |
| 132 | MP0003690_abnormal_glial_cell | 0.69286849 |
| 133 | MP0005535_abnormal_body_temperature | 0.68208320 |
| 134 | MP0001661_extended_life_span | 0.68125746 |
| 135 | MP0005266_abnormal_metabolism | 0.66127899 |
| 136 | MP0009053_abnormal_anal_canal | 0.65420698 |
| 137 | MP0003329_amyloid_beta_deposits | 0.62462503 |
| 138 | MP0000639_abnormal_adrenal_gland | 0.61367107 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.57800331 |
| 140 | MP0005448_abnormal_energy_balance | 0.56013974 |
| 141 | MP0005464_abnormal_platelet_physiology | 0.51933533 |
| 142 | MP0002822_catalepsy | 0.49972526 |
| 143 | MP0005395_other_phenotype | 0.48895417 |
| 144 | MP0002928_abnormal_bile_duct | 0.48138817 |
| 145 | MP0008874_decreased_physiological_sensi | 0.47067408 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.46902672 |
| 147 | MP0003718_maternal_effect | 0.46538380 |
| 148 | MP0008873_increased_physiological_sensi | 0.45603071 |
| 149 | MP0004782_abnormal_surfactant_physiolog | 0.43863361 |
| 150 | MP0003724_increased_susceptibility_to | 0.43657236 |
| 151 | * MP0001756_abnormal_urination | 0.43498545 |
| 152 | MP0004381_abnormal_hair_follicle | 0.42311154 |
| 153 | MP0002837_dystrophic_cardiac_calcinosis | 0.41917956 |
| 154 | MP0003436_decreased_susceptibility_to | 0.41852032 |
| 155 | MP0003953_abnormal_hormone_level | 0.41155548 |
| 156 | MP0005248_abnormal_Harderian_gland | 0.41136724 |
| 157 | * MP0002136_abnormal_kidney_physiology | 0.40068124 |
| 158 | MP0003075_altered_response_to | 0.40010379 |
| 159 | MP0005666_abnormal_adipose_tissue | 0.39027011 |
| 160 | MP0000579_abnormal_nail_morphology | 0.38976260 |
| 161 | MP0005166_decreased_susceptibility_to | 0.38571884 |
| 162 | MP0008872_abnormal_physiological_respon | 0.38539138 |
| 163 | MP0009672_abnormal_birth_weight | 0.37792115 |
| 164 | MP0009384_cardiac_valve_regurgitation | 0.34451024 |
| 165 | MP0002796_impaired_skin_barrier | 0.33387444 |
| 166 | MP0009115_abnormal_fat_cell | 0.33382240 |
| 167 | MP0001853_heart_inflammation | 0.32582339 |
| 168 | MP0001243_abnormal_dermal_layer | 0.32339495 |
| 169 | MP0000230_abnormal_systemic_arterial | 0.32247270 |
| 170 | MP0002168_other_aberrant_phenotype | 0.31785604 |
| 171 | MP0000249_abnormal_blood_vessel | 0.31541642 |
| 172 | MP0002970_abnormal_white_adipose | 0.30936895 |
| 173 | MP0004883_abnormal_blood_vessel | 0.30367770 |
| 174 | MP0006082_CNS_inflammation | 0.29357893 |
| 175 | MP0001881_abnormal_mammary_gland | 0.28961148 |
| 176 | MP0002090_abnormal_vision | 0.27485557 |
| 177 | MP0002060_abnormal_skin_morphology | 0.25904567 |
| 178 | * MP0001845_abnormal_inflammatory_respons | 0.25094097 |
| 179 | MP0005164_abnormal_response_to | 0.24212261 |
| 180 | MP0000427_abnormal_hair_cycle | 0.23340770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.47215087 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46928722 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.37427454 |
| 4 | Reduced antithrombin III activity (HP:0001976) | 6.99346070 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.76288030 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.64475413 |
| 7 | Abnormality of alanine metabolism (HP:0010916) | 6.63614559 |
| 8 | Hyperalaninemia (HP:0003348) | 6.63614559 |
| 9 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 6.63614559 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 6.49631525 |
| 11 | Xanthomatosis (HP:0000991) | 6.28332895 |
| 12 | Tongue fasciculations (HP:0001308) | 5.77183764 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 5.58602226 |
| 14 | Complement deficiency (HP:0004431) | 5.48251423 |
| 15 | Muscle fibrillation (HP:0010546) | 5.13990231 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.81997998 |
| 17 | Joint hemorrhage (HP:0005261) | 4.80305271 |
| 18 | Hyperammonemia (HP:0001987) | 4.61923667 |
| 19 | Epidermoid cyst (HP:0200040) | 4.59312742 |
| 20 | Renal tubular acidosis (HP:0001947) | 4.50898626 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45944282 |
| 22 | Proximal tubulopathy (HP:0000114) | 4.43119539 |
| 23 | Hyperglycinemia (HP:0002154) | 4.42082200 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40978182 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.34848872 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27031288 |
| 27 | Ketosis (HP:0001946) | 4.26982893 |
| 28 | Severe muscular hypotonia (HP:0006829) | 4.23368243 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 4.18128023 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16321673 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.16119703 |
| 32 | Fat malabsorption (HP:0002630) | 4.15464669 |
| 33 | Action tremor (HP:0002345) | 4.01003542 |
| 34 | Abnormality of complement system (HP:0005339) | 3.99655896 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91179711 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88614069 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.88614069 |
| 38 | Hyperglycinuria (HP:0003108) | 3.88440797 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.82510377 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80074214 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78218488 |
| 42 | Arthropathy (HP:0003040) | 3.77593916 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 3.77045783 |
| 44 | Cerebellar dysplasia (HP:0007033) | 3.73877996 |
| 45 | Spontaneous hematomas (HP:0007420) | 3.69326466 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.66038512 |
| 47 | Resting tremor (HP:0002322) | 3.64432164 |
| 48 | Nausea (HP:0002018) | 3.56583459 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37363741 |
| 50 | Hyperbilirubinemia (HP:0002904) | 3.36668479 |
| 51 | Menstrual irregularities (HP:0000858) | 3.35891987 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 3.35293418 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30692000 |
| 54 | Steatorrhea (HP:0002570) | 3.13345670 |
| 55 | Delayed CNS myelination (HP:0002188) | 3.11614872 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 3.09430977 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07360672 |
| 58 | Constricted visual fields (HP:0001133) | 3.07287782 |
| 59 | Ketoacidosis (HP:0001993) | 2.98823947 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.98687960 |
| 61 | Spontaneous abortion (HP:0005268) | 2.98619364 |
| 62 | Hypochromic microcytic anemia (HP:0004840) | 2.97085081 |
| 63 | Myocardial infarction (HP:0001658) | 2.96795691 |
| 64 | Renal dysplasia (HP:0000110) | 2.95490055 |
| 65 | Skin nodule (HP:0200036) | 2.83862208 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.76297361 |
| 67 | Hypomagnesemia (HP:0002917) | 2.75307156 |
| 68 | Metabolic acidosis (HP:0001942) | 2.73395069 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.65451153 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.63719947 |
| 71 | Acanthocytosis (HP:0001927) | 2.60601657 |
| 72 | Lethargy (HP:0001254) | 2.60284718 |
| 73 | Vascular calcification (HP:0004934) | 2.56205019 |
| 74 | Pachygyria (HP:0001302) | 2.54238139 |
| 75 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53424329 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 2.53424329 |
| 77 | Type II lissencephaly (HP:0007260) | 2.53267393 |
| 78 | Short hallux (HP:0010109) | 2.52947639 |
| 79 | Abnormality of magnesium homeostasis (HP:0004921) | 2.52917957 |
| 80 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.52836906 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.50796242 |
| 82 | White forelock (HP:0002211) | 2.50518646 |
| 83 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.50460041 |
| 84 | Spastic diplegia (HP:0001264) | 2.48327390 |
| 85 | Hypoglycemic seizures (HP:0002173) | 2.47505091 |
| 86 | Spastic paraparesis (HP:0002313) | 2.46879653 |
| 87 | Rhabdomyolysis (HP:0003201) | 2.46502887 |
| 88 | Abnormal sex determination (HP:0012244) | 2.46061654 |
| 89 | Sex reversal (HP:0012245) | 2.46061654 |
| 90 | Glomerulonephritis (HP:0000099) | 2.45054993 |
| 91 | Mitral stenosis (HP:0001718) | 2.44426134 |
| 92 | Cerebral edema (HP:0002181) | 2.44326994 |
| 93 | Upper limb muscle weakness (HP:0003484) | 2.43503814 |
| 94 | Cholelithiasis (HP:0001081) | 2.43411339 |
| 95 | Cholecystitis (HP:0001082) | 2.43194070 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.43194070 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41698786 |
| 98 | Gout (HP:0001997) | 2.40725450 |
| 99 | Renal tubular dysfunction (HP:0000124) | 2.37701826 |
| 100 | Irritability (HP:0000737) | 2.36515338 |
| 101 | Abnormal protein glycosylation (HP:0012346) | 2.36295078 |
| 102 | Abnormal glycosylation (HP:0012345) | 2.36295078 |
| 103 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.36295078 |
| 104 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.36295078 |
| 105 | Neonatal onset (HP:0003623) | 2.35437397 |
| 106 | Hand muscle atrophy (HP:0009130) | 2.34219533 |
| 107 | Neonatal death (HP:0003811) | 2.30047192 |
| 108 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.29771055 |
| 109 | Increased serum pyruvate (HP:0003542) | 2.27858082 |
| 110 | Cardiovascular calcification (HP:0011915) | 2.27002738 |
| 111 | Hypoplasia of the uterus (HP:0000013) | 2.26075445 |
| 112 | Fatigue (HP:0012378) | 2.24271775 |
| 113 | CNS hypomyelination (HP:0003429) | 2.23953207 |
| 114 | Amyloidosis (HP:0011034) | 2.23337500 |
| 115 | Esophageal varix (HP:0002040) | 2.20714031 |
| 116 | Malnutrition (HP:0004395) | 2.20483946 |
| 117 | Round ear (HP:0100830) | 2.20069716 |
| 118 | Gingival bleeding (HP:0000225) | 2.18962313 |
| 119 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.17720782 |
| 120 | Wrist flexion contracture (HP:0001239) | 2.17190562 |
| 121 | Anorexia (HP:0002039) | 2.17185239 |
| 122 | Abnormality of the renal cortex (HP:0011035) | 2.16332263 |
| 123 | Diaphragmatic weakness (HP:0009113) | 2.15289263 |
| 124 | Menorrhagia (HP:0000132) | 2.14438746 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.13844790 |
| 126 | Brushfield spots (HP:0001088) | 2.13260710 |
| 127 | Pancreatitis (HP:0001733) | 2.12250767 |
| 128 | Enlarged kidneys (HP:0000105) | 2.10474877 |
| 129 | Late onset (HP:0003584) | 2.09703903 |
| 130 | Mixed hearing impairment (HP:0000410) | 2.08178538 |
| 131 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.07299969 |
| 132 | Thrombophlebitis (HP:0004418) | 2.06069738 |
| 133 | Patchy hypopigmentation of hair (HP:0011365) | 2.05797195 |
| 134 | Vomiting (HP:0002013) | 2.03886800 |
| 135 | Poikilocytosis (HP:0004447) | 2.03445969 |
| 136 | Abnormality of the gallbladder (HP:0005264) | 2.03400328 |
| 137 | Coxa valga (HP:0002673) | 2.02018324 |
| 138 | Postural tremor (HP:0002174) | 2.01684502 |
| 139 | J-shaped sella turcica (HP:0002680) | 2.01264100 |
| 140 | Opisthotonus (HP:0002179) | 2.00858796 |
| 141 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00597959 |
| 142 | Generalized aminoaciduria (HP:0002909) | 2.00170612 |
| 143 | Conjunctival telangiectasia (HP:0000524) | 1.99888688 |
| 144 | Glycosuria (HP:0003076) | 1.99646514 |
| 145 | Abnormality of urine glucose concentration (HP:0011016) | 1.99646514 |
| 146 | Abnormality of the tricuspid valve (HP:0001702) | 1.99292381 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.97585422 |
| 148 | Atonic seizures (HP:0010819) | 1.96496927 |
| 149 | Azoospermia (HP:0000027) | 1.96087873 |
| 150 | Rickets (HP:0002748) | 1.92901555 |
| 151 | Hypergonadotropic hypogonadism (HP:0000815) | 1.91523738 |
| 152 | Respiratory distress (HP:0002098) | 1.89266976 |
| 153 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.88877118 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.88358710 |
| 155 | Abnormal cartilage morphology (HP:0002763) | 1.88127155 |
| 156 | Hepatic necrosis (HP:0002605) | 1.86126594 |
| 157 | Hypophosphatemic rickets (HP:0004912) | 1.85748719 |
| 158 | Renal cortical cysts (HP:0000803) | 1.85654086 |
| 159 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85410383 |
| 160 | Stridor (HP:0010307) | 1.85270765 |
| 161 | Hyporeflexia of lower limbs (HP:0002600) | 1.85144193 |
| 162 | Intention tremor (HP:0002080) | 1.84693787 |
| 163 | Alkalosis (HP:0001948) | 1.82374379 |
| 164 | Poor suck (HP:0002033) | 1.81956877 |
| 165 | Abnormal tarsal ossification (HP:0008369) | 1.81836605 |
| 166 | Abnormality of proline metabolism (HP:0010907) | 1.81680695 |
| 167 | Hydroxyprolinuria (HP:0003080) | 1.81680695 |
| 168 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81551767 |
| 169 | Elevated hepatic transaminases (HP:0002910) | 1.80988109 |
| 170 | Thickened helices (HP:0000391) | 1.80925087 |
| 171 | Abnormality of glycolysis (HP:0004366) | 1.80631898 |
| 172 | Fetal akinesia sequence (HP:0001989) | 1.80537131 |
| 173 | Status epilepticus (HP:0002133) | 1.80513755 |
| 174 | Attenuation of retinal blood vessels (HP:0007843) | 1.78917628 |
| 175 | Hyperglycemia (HP:0003074) | 1.78306718 |
| 176 | High pitched voice (HP:0001620) | 1.77503581 |
| 177 | Distal upper limb amyotrophy (HP:0007149) | 1.77292726 |
| 178 | Upper limb amyotrophy (HP:0009129) | 1.77292726 |
| 179 | Prominent supraorbital ridges (HP:0000336) | 1.75230973 |
| 180 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74508531 |
| 181 | Abnormality of vitamin metabolism (HP:0100508) | 1.73758232 |
| 182 | Nephritis (HP:0000123) | 1.73697748 |
| 183 | Disproportionate short-trunk short stature (HP:0003521) | 1.71637531 |
| 184 | Abnormality of the vitreous humor (HP:0004327) | 1.70975337 |
| 185 | Clumsiness (HP:0002312) | 1.69461186 |
| 186 | Pulmonary embolism (HP:0002204) | 1.68137668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR1B | 7.18135408 |
| 2 | BCKDK | 7.08247619 |
| 3 | SIK1 | 4.62055987 |
| 4 | FGFR4 | 4.55913766 |
| 5 | CDK8 | 4.52812027 |
| 6 | ERN1 | 4.26116594 |
| 7 | TGFBR1 | 3.86866173 |
| 8 | TAOK3 | 3.17062389 |
| 9 | INSRR | 3.13057747 |
| 10 | ERBB4 | 3.04010185 |
| 11 | MARK3 | 2.66748870 |
| 12 | CDK9 | 2.59799434 |
| 13 | TESK1 | 2.58868021 |
| 14 | MAP2K4 | 2.39511517 |
| 15 | PKN2 | 2.28332673 |
| 16 | PNCK | 2.19277302 |
| 17 | ACVR1B | 2.14792761 |
| 18 | MST1R | 2.14558926 |
| 19 | FLT3 | 1.96723280 |
| 20 | MAPK11 | 1.91960701 |
| 21 | OBSCN | 1.89541590 |
| 22 | PIK3CG | 1.79800483 |
| 23 | LATS1 | 1.70873254 |
| 24 | TYK2 | 1.68778291 |
| 25 | FGR | 1.67703676 |
| 26 | TRIB3 | 1.67244087 |
| 27 | PRKG2 | 1.55022638 |
| 28 | DAPK2 | 1.52332897 |
| 29 | ABL2 | 1.50143775 |
| 30 | PHKG1 | 1.49382803 |
| 31 | PHKG2 | 1.49382803 |
| 32 | LIMK1 | 1.47069544 |
| 33 | FRK | 1.45408527 |
| 34 | FGFR2 | 1.45007348 |
| 35 | PTK6 | 1.42955391 |
| 36 | NEK9 | 1.42000557 |
| 37 | ZAK | 1.41880227 |
| 38 | KDR | 1.27098769 |
| 39 | JAK2 | 1.24050256 |
| 40 | MAP3K7 | 1.22983256 |
| 41 | PRKAA2 | 1.15152880 |
| 42 | PINK1 | 1.11945787 |
| 43 | CDK3 | 1.11680406 |
| 44 | ADRBK2 | 1.06456314 |
| 45 | ERBB2 | 1.05641044 |
| 46 | GRK6 | 1.04367231 |
| 47 | TBK1 | 1.04243149 |
| 48 | JAK1 | 1.03937670 |
| 49 | MAP2K3 | 1.03289579 |
| 50 | MAP3K14 | 1.02024328 |
| 51 | MAPK4 | 1.01377722 |
| 52 | LMTK2 | 0.98621743 |
| 53 | NTRK2 | 0.96283767 |
| 54 | MAP3K10 | 0.94544913 |
| 55 | JAK3 | 0.94078132 |
| 56 | PRKCZ | 0.93414067 |
| 57 | MAPK15 | 0.92792950 |
| 58 | STK38L | 0.89008050 |
| 59 | MKNK2 | 0.88417182 |
| 60 | MET | 0.85182430 |
| 61 | MAP3K3 | 0.84319369 |
| 62 | MAPK12 | 0.82078181 |
| 63 | CDK6 | 0.80489179 |
| 64 | EPHB1 | 0.79901700 |
| 65 | CDK7 | 0.78594576 |
| 66 | PRKACG | 0.76763599 |
| 67 | EPHA3 | 0.76608857 |
| 68 | TIE1 | 0.75722201 |
| 69 | WNK4 | 0.75323786 |
| 70 | CAMK1D | 0.74497862 |
| 71 | RPS6KB1 | 0.73622408 |
| 72 | CAMK2G | 0.73621132 |
| 73 | FGFR1 | 0.72101124 |
| 74 | CSK | 0.72030432 |
| 75 | AKT2 | 0.71200050 |
| 76 | MAP3K11 | 0.70943879 |
| 77 | MAP2K6 | 0.68139970 |
| 78 | GSK3A | 0.67542924 |
| 79 | DYRK1B | 0.66447547 |
| 80 | SGK3 | 0.66133079 |
| 81 | PRKAA1 | 0.65902759 |
| 82 | IRAK3 | 0.62979031 |
| 83 | MAPK7 | 0.61608950 |
| 84 | RPS6KA5 | 0.61065394 |
| 85 | FGFR3 | 0.60641096 |
| 86 | RIPK1 | 0.58787690 |
| 87 | CSF1R | 0.56984202 |
| 88 | TGFBR2 | 0.55484804 |
| 89 | MYLK | 0.54934191 |
| 90 | IKBKE | 0.54827082 |
| 91 | PTK2 | 0.53157258 |
| 92 | TNK2 | 0.51670159 |
| 93 | PRKCQ | 0.51116110 |
| 94 | EPHA4 | 0.50626217 |
| 95 | PDGFRB | 0.50437296 |
| 96 | TLK1 | 0.50115467 |
| 97 | PDPK1 | 0.49877174 |
| 98 | SGK2 | 0.49842597 |
| 99 | CSNK1G1 | 0.49831293 |
| 100 | GRK1 | 0.47329616 |
| 101 | ADRBK1 | 0.47312857 |
| 102 | TAOK2 | 0.46552451 |
| 103 | ITK | 0.46043975 |
| 104 | CCNB1 | 0.46025632 |
| 105 | IGF1R | 0.45616938 |
| 106 | MAP3K5 | 0.45104959 |
| 107 | MAP3K13 | 0.43925319 |
| 108 | PKN1 | 0.43850870 |
| 109 | TAF1 | 0.43397249 |
| 110 | RET | 0.43217212 |
| 111 | MAP2K1 | 0.41501440 |
| 112 | PRKCG | 0.40843902 |
| 113 | CDK4 | 0.39518544 |
| 114 | WNK1 | 0.38645372 |
| 115 | MAP3K6 | 0.36639343 |
| 116 | ICK | 0.35538400 |
| 117 | EGFR | 0.35157523 |
| 118 | MUSK | 0.34570513 |
| 119 | MTOR | 0.34396080 |
| 120 | SGK223 | 0.33915400 |
| 121 | SGK494 | 0.33915400 |
| 122 | MELK | 0.32799629 |
| 123 | BMX | 0.32587474 |
| 124 | PBK | 0.32354856 |
| 125 | CAMK4 | 0.31733867 |
| 126 | PDK1 | 0.31561412 |
| 127 | CSNK1G2 | 0.29572814 |
| 128 | IRAK1 | 0.29406551 |
| 129 | IRAK2 | 0.29160734 |
| 130 | CSNK1A1 | 0.27641656 |
| 131 | MAP4K1 | 0.27392105 |
| 132 | NME1 | 0.26876361 |
| 133 | PIK3CA | 0.26718257 |
| 134 | DMPK | 0.26623744 |
| 135 | CAMK1G | 0.26616089 |
| 136 | LATS2 | 0.26278805 |
| 137 | CDK14 | 0.26268809 |
| 138 | PRKCA | 0.26199438 |
| 139 | MAP3K1 | 0.25350230 |
| 140 | CSNK1G3 | 0.25091798 |
| 141 | AKT3 | 0.23932309 |
| 142 | SGK1 | 0.23594908 |
| 143 | PLK4 | 0.22629145 |
| 144 | ABL1 | 0.22525530 |
| 145 | PDK4 | 0.22151562 |
| 146 | PDK3 | 0.22151562 |
| 147 | ROCK1 | 0.17920746 |
| 148 | CDK5 | 0.17592071 |
| 149 | CAMK1 | 0.17442810 |
| 150 | PRKG1 | 0.17368478 |
| 151 | PRKCE | 0.17270605 |
| 152 | RPS6KA1 | 0.17198045 |
| 153 | NTRK3 | 0.16019945 |
| 154 | MAP2K7 | 0.15613024 |
| 155 | CAMK2D | 0.15102464 |
| 156 | RPS6KB2 | 0.11832632 |
| 157 | EPHB2 | 0.11780772 |
| 158 | MKNK1 | 0.11609792 |
| 159 | CAMK2B | 0.10552454 |
| 160 | EIF2AK3 | 0.10322708 |
| 161 | AKT1 | 0.07742104 |
| 162 | STK38 | 0.07135013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.55281649 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.63157682 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44527967 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37073389 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09987286 |
| 6 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.80026858 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76901915 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70042935 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69157517 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.67958472 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59984122 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53794238 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47060047 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36482585 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26880953 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14131383 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13207064 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.07132112 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95112880 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94984109 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92871428 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91514729 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90644700 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.90510942 |
| 25 | Mineral absorption_Homo sapiens_hsa04978 | 1.88585452 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85862366 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.82744164 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79824339 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79013732 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78507924 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76024877 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75557985 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72247407 |
| 34 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.71698246 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70460466 |
| 36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.67886688 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67430323 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65458780 |
| 39 | Morphine addiction_Homo sapiens_hsa05032 | 1.64258562 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58113628 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57830534 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56399089 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50004812 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49763825 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.49457341 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44494902 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.41303050 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36037108 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33060314 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32574186 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 1.31857919 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31461851 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 1.30627127 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30014927 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 1.27603895 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 1.26021490 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 1.24960115 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.21133351 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21008564 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20876536 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19765408 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18963521 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18599654 |
| 64 | Cocaine addiction_Homo sapiens_hsa05030 | 1.18063901 |
| 65 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.16722153 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.16509311 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15964719 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14027522 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11884191 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 1.09372505 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04206296 |
| 72 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.02602209 |
| 73 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01410090 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.98867929 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97432051 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96716017 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96523544 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96345005 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95147280 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95006915 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94013278 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92025593 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90795440 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86781827 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84809011 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83862242 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83578294 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82697182 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81514160 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.80978991 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80654144 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.79081716 |
| 93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77649276 |
| 94 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77550140 |
| 95 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75244494 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75174100 |
| 97 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74433533 |
| 98 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72137128 |
| 99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.70715267 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70633606 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70142968 |
| 102 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69947837 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67972819 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66334287 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63445842 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62387692 |
| 107 | Alcoholism_Homo sapiens_hsa05034 | 0.58070595 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56709838 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.54505950 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54346145 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53330929 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50664978 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47085744 |
| 114 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46771931 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46699958 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45492634 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39490369 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.38179747 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24331087 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24243404 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.23474382 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23433382 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22175490 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21306578 |
| 125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18043293 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15392212 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10859961 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02369642 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2555508 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2389620 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | -0.2324603 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2302400 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2226324 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1973361 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1970144 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1935943 |
| 137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1929948 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | -0.1799802 |
| 139 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1731733 |
| 140 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1605736 |
| 141 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1533669 |
| 142 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1501609 |
| 143 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1335942 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1287156 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0940985 |
| 146 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0872035 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0853265 |
| 148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0670429 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0489219 |

